Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 10, 2012Diabetes Technology & Therapeutics

Dipeptidyl Peptidase-4 Inhibitors: 3 Years of Experience

View Full Paper
Ask AI
Bookmark
Share

Authors

GDGiuseppe DerosaGeneral / Preventive / LipidsPMPamela MaffioliOslo University Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Derosa et al. (2012) studied this question.

synapsesocial.com/papers/6a7135e184cc45bb7bdfe708https://doi.org/10.1089/dia.2011.0204
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes2009 · 48 citations
  2. 2The effect of initial therapy with the fixed‐dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus2011 · 91 citations
  3. 3Sulfonylureas in NIDDM1992 · 405 citations
  4. 4Effects of Intensive Glucose Lowering in Type 2 Diabetes2008 · 7,952 citations
  5. 5Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial2010 · 174 citations